Notably, participants treated with metformin in the Multi-Ethnic Study of Atherosclerosis (MESA) study exhibit significantly elevated Lac-Phe levels compared to non-metformin users (Li et al., 2024)
This policy ensures that patients can confidently explore their treatment options, knowing they will not incur unnecessary costs if LIPO-C therapy is not deemed suitable for their needs
Approved ASO drugs target exon 45 (casimersen), 264,496 exon 51 (eteplirsen), 497,498 and exon 53 (golodirsen and viltolarsen) 80,263 to induce specific exon skipping in the dystrophin gene, thus delaying disease progression
For those familiar with general peptide stability at room temperature guidelines, cerebrolysin is relatively stable compared to many synthetic peptides, but temperature extremes should still be avoided